Search

everythinglearnresearchcommunity

for

Search:↓

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Androgen and Wnt signals are crucial for developing and functioning male genitalia and erectile tissues.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.